ArticleVeterinary medicine international2026
Association Between the nt230(del4) Mutation and c.-6-180T>G Polymorphism in the Canine ABCB1 Gene.
Article in Veterinary medicine international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between the nt230(del4) Mutation and c.-6-180T>G Polymorphism in the Canine ABCB1 Gene.Veterinary medicine international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 4-base pair deletion in the ABCB1 (MDR1) gene, resulting in a frameshift and truncated, nonfunctional P-glycoprotein, is frequently observed in certain dog breeds and is known to cause drug sensitivity. Another variant, a single nucleotide substitution (c.-6-180T > G) located near the gene's promoter region, has also been identified; however, its clinical significance remains unclear. This study aimed to determine the genotype distribution of the nt230(del4) deletion and the c.-6-180T > G substitution across various dog breeds and to evaluate whether an association exists between these variants. A total of 263 client-owned dogs from 17 breeds were genotyped for both mutations. Genomic DNA was extracted using a spin column-based method. The deletion was detected using a modified allele-specific real-time PCR assay, and the SNP was assessed via PCR followed by RFLP analysis. The nt230(del4) mutation was identified exclusively in collie-lineage breeds, including collie, Shetland sheepdog, Australian shepherd, bobtail, and white Swiss shepherd. The c.-6-180T > G SNP was widespread across all breeds, with a G allele frequency of 35%. Genotype distribution included 111 T/T homozygotes, 119 T/G heterozygotes, and 33 G/G homozygotes. Notably, all individuals carrying the deletion also possessed at least one G allele, suggesting a co-occurrence between the two variants. The observed association between the nt230(del4) deletion and the c.-6-180T > G SNP in this cohort may reflect shared ancestry and/or local linkage disequilibrium. Further research is warranted to explore the functional consequences of this SNP and its potential role in canine drug response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.